Guerbet has received the CE Mark for its new liver AI software, DUOnco Liver.
DUOnco Liver is designed to detect focal lesions in the liver during portal phase scans and aims to address the difficulty of lesion measurements and follow-up, according to Guerbet. Integrated into Guerbet's Intrasense products, DuOnco Liver will be among the 2.0 version of Liflow's set of multiorgan AI algorithms, Guerbet said.
